All stock lists
Adlai Nortye Group Ltd. (NASDAQ:ANL)
SG · Delayed Price · Currency is USD
Healthcare · Biotechnology
10.72+0.14 (+1.37%)
Insider Score
––Not scored
ANL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ANL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 7.34 M | 7.34 M | 2.50 M | 2.50 M | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 7.34 M | 7.34 M | 2.50 M | 2.50 M | 0.00 | 0.00 |
| SG&A Expense | 2.91 M | 2.91 M | 2.10 M | 2.10 M | 2.03 M | 2.03 M |
| R&D Expense | 7.32 M | 7.32 M | 8.79 M | 8.79 M | 7.62 M | 7.62 M |
| Operating Expenses | 10.22 M | 10.22 M | 10.76 M | 10.76 M | 9.59 M | 9.59 M |
| Operating Income | -2.88 M | -2.88 M | -8.26 M | -8.26 M | -9.59 M | -9.59 M |
| Pretax Income | -2.67 M | -2.67 M | -8.60 M | -8.60 M | -9.17 M | -9.17 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.67 M | -2.67 M | -8.60 M | -8.60 M | -9.17 M | -9.17 M |
| EPS (Basic) | -0.17 | -0.17 | -0.81 | -0.81 | -0.87 | -0.87 |
| EPS (Diluted) | -0.17 | -0.17 | -0.81 | -0.81 | -0.87 | -0.87 |
| Shares Outstanding | 15.92 M | 15.92 M | 10.66 M | 10.66 M | 10.65 M | 10.65 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.